About Robin Blaney

Robin Blaney is a partner at Covington & Burling LLP who advises pharmaceutical, biotechnology, and medical device companies on a broad range of regulatory, compliance, transactional, and legislative matters, as well as commercial agreements spanning the full product life cycle. He regularly supports human and veterinary pharmaceutical companies on advertising and GxP issues, including clinical trials, pharmacovigilance, and manufacturing. Robin also advises on the regulatory aspects of M&A, licensing, and collaborative transactions, with significant experience in transitional regulatory, and supply arrangements. His commercial expertise includes clinical trial, manufacturing, and distribution agreements, and he has notable experience structuring international distribution and licensing frameworks.